Kura Oncology KURA
NASDAQ KURA
$10.65 -0.06 (-0.56%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kura Oncology (KURA) Total Non-Current Liabilities (2014 - 2026)

Updated

Kura Oncology's Total Non-Current Liabilities was $535.74 million in Q2 2026, up 43.1% from $374.34 million a year earlier but down 1.0% from the prior quarter.

Analysis

Kura Oncology (KURA) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Kura Oncology came in at $561.06 million, up 62.8% from FY2024.

  • Total Non-Current Liabilities has now increased for four consecutive years, with a five-year compound annual growth rate of 73.3% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $344.72 million in FY2024 (+576.5%), $50.96 million in FY2023 (+42.5%), $35.76 million in FY2022 (+32.1%) and $27.07 million in FY2021 (-24.6%).
  • Quarterly Total Non-Current Liabilities has moved between $21.48 million (Q2 2022) and $561.06 million (Q4 2025) over five years.
  • Compared with a year earlier, Total Non-Current Liabilities has increased for 16 straight quarters, with growth averaging 346.7% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q1 2025 (growth of 688.0%); the worst was Q1 2022 (a decline of 35.5%).
  • Per Business Quant data, KURA's Total Non-Current Liabilities in the three quarters before Q2 2026 was $541.23 million (Q1 2026), $561.06 million (Q4 2025) and $403.86 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Kura Oncology 952.70 Mn 952.70 Mn 20.63 Mn 535.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 535.74 Mn
Mar 31, 2026 541.23 Mn
Dec 31, 2025 561.06 Mn
Sep 30, 2025 403.86 Mn
Jun 30, 2025 374.34 Mn
Mar 31, 2025 377.22 Mn
Dec 31, 2024 344.72 Mn
Sep 30, 2024 53.60 Mn
Jun 30, 2024 47.87 Mn
Mar 31, 2024 47.87 Mn
Dec 31, 2023 50.96 Mn
Sep 30, 2023 43.27 Mn
Jun 30, 2023 34.60 Mn
Mar 31, 2023 30.44 Mn
Dec 31, 2022 35.76 Mn
Sep 30, 2022 27.83 Mn
Jun 30, 2022 21.48 Mn
Mar 31, 2022 21.84 Mn
Dec 31, 2021 27.07 Mn
Sep 30, 2021 27.03 Mn
API Access

Kura Oncology Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=KURA&period=max&api_key=YOUR_API_KEY